srch

01.09.2021 · Biopharma merger and acquisition (M&A) activity in 2021 so far is showing signs of returning to typical levels following the disruption of the pandemic.

European Pharmaceutical Review investigates the financial results of some of the top 10 pharma and biopharma companies worldwide.

Biopharma merger and acquisition (M&A) activity was subdued in 2021, and it would have approached a record low for recent years but for a flurry of deals in ...

M&A deal volume throughout 2021 gradually dropped throughout the ... 1 | Biopharma dealmaking in 2021. a | Mergers and acquisitions (M&As).

Biopharma dealmaking in 2021 Nat Rev Drug Discov. 2022 Feb;21(2):93-94. doi: 10.1038/d41573-022-00017-1. Authors Amanda Micklus, Patricia Giglio ...

September 28-29, 2022 Proudly part of Biotech Week Boston, Boston Convention and Exhibition Center Where dynamic life science leaders partner to drive the future of drug development Thank you for being part of BioPharm America 2021! On behalf of EBD Group, thank you for participating in the 2021 digital edition of this event.

Published: Jan 06, 2022 By Mark Terry. News. The biggest story in biopharma, at least in 2021, isn't really one story, but many. Going through the most ...

Women in Biopharma 2021. women in biopharma. 2021. 20 of the top women leaders in biopharma R&D 2021. 7 DECEMBER 2:00 - 3:35pm EST ...

08.01.2021 · Seven Biopharma Trends to Watch in 2021 Besides building momentum against COVID-19, biopharma will accelerate its progress in …

Jan 18, 2022 · Biopharma partnering got off to a strong start in Q1, then declined sharply in Q2 before gradually gaining momentum throughout the remainder of 2021. Despite the varying quarterly trends, 2021...

Biopharma 2021: The resilience rethink · At no point in the modern era have the health and resilience of the biopharma industry been more crucial. · “ Developing ...

Seven Biopharma Trends to Watch in 2021 · 1. COVID-19: Seeing the finish line · 2. Gene therapy: Big pharma, big deals · 3. Genome editing: CRISPR ...

A surge in deal activity over the last few months has placed 2021 in the running for beating 2020, the best year on record, and becoming the ...

In many respects, 2021 was a positive experience for the pharma and biotech industries. It was an extraordinarily successful year for innovation ...

Biopharma 2021: The resilience rethink. In an age of crisis, can the biopharma industry withstand global shocks? Share this article. At no point in the modern era have the health and resilience of ...

BIOPHARMA 2021: THE RESILIENCE RETHINK In an age of crisis, can the biopharma industry withstand global shocks? This research was conducted by Longitude, a Financial Times group company and part of FT Marketing Services.

Top 10 Bio/Pharma Developments in 2021. Which news developments in the bio/pharmaceutical industry from 2021 were of greatest significance?

18.01.2022 · Biopharma’s appetite for high-value partnerships continued into 2021, as 55 deals reached the billion-dollar-plus mark in 2021, compared with 53 in this category in 2020.

Women in Biopharma 2021. ... In our 3rd annual Women in Biopharma R&D report, Endpoints News continues its celebration of women who are blazing trails in ...